Skip to content
10-K

Annual Report

bluebird bio, Inc.

0001293971-24-000037

← back to feed
Filed
Sep 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Sep 11, 2024 193.91M sh
Shares Diluted FY 2023 · Dec 31, 2022 78.59M sh
Capex FY 2023 · Dec 31, 2022 $8.21M
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$316.22M
Cash And Equivalents FY 2023 · Dec 31, 2022 $113.01M
Current Liabilities restated FY 2023 · Dec 31, 2022 $156.58M
Total Liabilities restated FY 2023 · Dec 31, 2022 $435.48M
Current Assets restated FY 2023 · Dec 31, 2022 $203.57M
Total Assets restated FY 2023 · Dec 31, 2022 $569.81M
Eps Diluted restated FY 2023 · Dec 31, 2022 −$2.93
Eps Basic restated FY 2023 · Dec 31, 2022 −$2.93
Sga Expense restated FY 2023 · Dec 31, 2022 $140.33M
Rd Expense restated FY 2023 · Dec 31, 2022 $200.44M
Net Income restated FY 2023 · Dec 31, 2022 −$230.34M
Operating Income restated FY 2023 · Dec 31, 2022 −$250.19M
Gross Profit FY 2023 · Dec 31, 2022 −$6.48M
Cost Of Revenue FY 2023 · Dec 31, 2022 $10.08M
Revenue restated FY 2023 · Dec 31, 2022 $2.74M
Stockholders Equity restated FY 2023 · Dec 31, 2021 $276.13M